View up-to-date information on Arcus Biosciences Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 30 Nov 2021 | Taiho Pharma Exercises License Option from Arcus Biosciences for AB154 and AB308 | Licensing Agreement |
Taiho Pharmaceutical Co Ltd
|
Arcus Biosciences Inc |
| 15 Mar 2021 | Arcus Biosciences Inc Enters Phase I/II Clinical Trial Agreement with ICON Plc for etrumadenant, quemliclustat (GDCT0407184) | Contract Service Agreement |
Arcus Biosciences Inc
|
ICON Plc |
| 15 Mar 2021 | Arcus Biosciences Inc Enters Phase I/II Clinical Trial Agreement with ICON Plc for etrumadenant, quemliclustat (GDCT0407184) | Contract Service Agreement |
Arcus Biosciences Inc
|
ICON Plc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward